Northern Trust’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.4K | Sell |
38,996
-87,959
| -69% | -$141K | ﹤0.01% | 4199 |
|
|
2025
Q1 | $155K | Buy |
126,955
+15,205
| +14% | +$18.6K | ﹤0.01% | 4009 |
|
|
2024
Q4 | $211K | Sell |
111,750
-7,119
| -6% | -$13.5K | ﹤0.01% | 3973 |
|
|
2024
Q3 | $635K | Buy |
118,869
+35,432
| +42% | +$189K | ﹤0.01% | 3513 |
|
|
2024
Q2 | $616K | Buy |
83,437
+22,324
| +37% | +$165K | ﹤0.01% | 3429 |
|
|
2024
Q1 | $730K | Sell |
61,113
-7,570
| -11% | -$90.4K | ﹤0.01% | 3428 |
|
|
2023
Q4 | $541K | Buy |
68,683
+5,866
| +9% | +$46.2K | ﹤0.01% | 3513 |
|
|
2023
Q3 | $278K | Buy |
62,817
+52
| +0.1% | +$230 | ﹤0.01% | 3697 |
|
|
2023
Q2 | $2.18M | Buy |
62,765
+2,646
| +4% | +$92.1K | ﹤0.01% | 2959 |
|
|
2023
Q1 | $1.31M | Buy |
60,119
+12,809
| +27% | +$279K | ﹤0.01% | 3120 |
|
|
2022
Q4 | $1.02M | Sell |
47,310
-1,507
| -3% | -$32.6K | ﹤0.01% | 3247 |
|
|
2022
Q3 | $1.19M | Buy |
48,817
+72
| +0.1% | +$1.76K | ﹤0.01% | 3254 |
|
|
2022
Q2 | $995K | Sell |
48,745
-329
| -0.7% | -$6.72K | ﹤0.01% | 3344 |
|
|
2022
Q1 | $1.75M | Buy |
49,074
+8,197
| +20% | +$292K | ﹤0.01% | 3162 |
|
|
2021
Q4 | $1.11M | Sell |
40,877
-889
| -2% | -$24.2K | ﹤0.01% | 3499 |
|
|
2021
Q3 | $1.81M | Sell |
41,766
-2,255
| -5% | -$97.9K | ﹤0.01% | 3341 |
|
|
2021
Q2 | $2.19M | Buy |
44,021
+35,346
| +407% | +$1.76M | ﹤0.01% | 3310 |
|
|
2021
Q1 | $390K | Buy |
8,675
+3,927
| +83% | +$177K | ﹤0.01% | 3897 |
|
|
2020
Q4 | $123K | Sell |
4,748
-335
| -7% | -$8.68K | ﹤0.01% | 4074 |
|
|
2020
Q3 | $73K | Buy |
5,083
+1,368
| +37% | +$19.6K | ﹤0.01% | 4035 |
|
|
2020
Q2 | $96K | Buy |
3,715
+2,151
| +138% | +$55.6K | ﹤0.01% | 3932 |
|
|
2020
Q1 | $19K | Buy |
+1,564
| New | +$19K | ﹤0.01% | 4095 |
|